UCB CELLTECH
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 1925-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
8
Active:0
Completed:6
Trial Phases
2 Phases
Phase 1:5
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (62.5%)Phase 2
3 (37.5%)A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- UCB Celltech
- Target Recruit Count
- 12
- Registration Number
- NCT05028127
UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- UCB Celltech
- Target Recruit Count
- 27
- Registration Number
- NCT02610543
- Locations
- 🇫🇷
Ss0004 34, Brest, France
🇫🇷Ss0004 30, Le Kremlin-Bicêtre, France
🇫🇷Ss0004 35, Strasbourg, France
A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis
- First Posted Date
- 2015-08-20
- Last Posted Date
- 2015-08-20
- Lead Sponsor
- UCB Celltech
- Target Recruit Count
- 39
- Registration Number
- NCT02529956
- Locations
- 🇬🇧
1, Harrow, United Kingdom
Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis
Phase 2
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2015-04-30
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- UCB Celltech
- Target Recruit Count
- 159
- Registration Number
- NCT02430909
- Locations
- 🇨🇿
Ra0123 101, Praha 7, Czechia
🇭🇺Ra0123 203, Balatonfured, Hungary
🇭🇺Ra0123 201, Budapest, Hungary
A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2014-08-19
- Last Posted Date
- 2015-10-05
- Lead Sponsor
- UCB Celltech
- Target Recruit Count
- 41
- Registration Number
- NCT02220153
- Locations
- 🇬🇧
001, Harrow, Middlesex, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found